Health-related quality of life (HRQOL) and patient-centred outcomes with olaparib maintenance post-chemotherapy in patients with germline BRCA-mutated platinum-sensitive relapsed serous ovarian cancer (PSR SOC).
Authors
Friedlander, MGebski, V
Gibbs, E
Bloomfield, R
Hilpert, F
Wenzel, L
Joly, F
Eek, D
Rodrigues, M
Clamp, Andrew R
Penson, R
Provencher, D
Korach, J
Huzarski, T
Vidal, L
Salutari, V
Scott, C
Nicoletto, M
Tamura, K
Pujade-Lauraine, E
Affiliation
Prince of Wales Hospital, Department of Medical Oncology- University of New South Wales Clinical School, Randwick, AustraliaIssue Date
2017